儿童期与成人期系统性红斑狼疮患者骨坏死的遗传学研究
在两个三级医疗中心纳入940例符合SLE分类标准的患者,其中87%为女性、56%为儿童期起病,7.6%(n=71)经影像学确认存在症状性骨坏死。对儿童期与成人期SLE分别进行骨坏死全基因组关联分析并荟萃分析,发现2号染色体WIPF1内含子变异rs34118383与骨坏死风险相关(HR=3.2,95%CI:2.2,4.8;P=1.0×10-8),该效应独立于糖皮质激素暴露,且在儿童期与成人期SLE中相似。
要点
- 940例SLE患者中7.6%(n=71)经影像学确认出现症状性骨坏死。
- rs34118383(WIPF1内含子变异)与骨坏死风险相关,HR=3.2(95%CI:2.2,4.8;P=1.0×10-8)。
- 该变异对骨坏死时间的效应在儿童期与成人期SLE中相似,且独立于糖皮质激素暴露。
核心结论
- 发现WIPF1内含子变异与SLE随访期间骨坏死风险增加相关(HR=3.2,95%CI:2.2,4.8;P=1.0×10-8),独立于糖皮质激素暴露。
- 该单核苷酸多态性对骨坏死时间的效应在儿童期与成人期SLE中相似。
- 作者认为这一新发现是潜在的骨坏死风险位点,并指出结果需要重复验证。
研究设计与样本
- 从两个三级医疗中心纳入符合SLE分类标准的940例患者,87%为女性,56%为儿童期起病。
- 参与者有前瞻性收集的临床数据,并在多民族芯片上进行基因分型,未分型的单核苷酸多态性经填充,祖先背景用主成分推断。
- 结局为影像学确认的症状性骨坏死,对骨坏死进行全基因组关联分析的时间-事件分析和逻辑回归,协变量包括性别、SLE诊断年龄、5个祖先主成分、糖皮质激素使用和选定的SLE表现。
- 对儿童期起病和成人期起病SLE分别分析,并用逆方差加权法荟萃分析,全基因组显著性阈值为P<5×10-8。
主要发现
- 940例参与者中骨坏死占7.6%(n=71),SLE诊断中位年龄16.9岁(四分位距:13.5,29.3),中位随访8.0年(四分位距:4.2,15.7)。
- 对儿童期和成人期SLE的骨坏死时间-事件分析荟萃全基因组关联分析纳入4 431 911个单核苷酸多态性,发现2号染色体单核苷酸多态性rs34118383达到显著(次要等位基因频率=0.18),位于WIPF1内含子(风险比=3.2[95%CI:2.2,4.8];P=1.0×10-8)。
关键数值与推荐
- 全基因组显著性定义为P<5×10-8。
- rs34118383次要等位基因频率=0.18,位于WIPF1内含子,风险比=3.2(95%CI:2.2,4.8;P=1.0×10-8)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出结果需要重复验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Genetics plays an important role in SLE risk, as well as osteonecrosis (ON), a significant and often debilitating complication of SLE. We aimed to identify genetic risk loci for ON in people with childhood-onset (cSLE) and adult-onset (aSLE) SLE. METHODS: We enrolled participants from two tertiary care centres who met classification criteria for SLE. Participants had prospectively collected clinical data and were genotyped on a multiethnic array. Un-genotyped single nucleotide polymorphisms (SNPs) were imputed, and ancestry was inferred using principal components (PCs). Our outcome was symptomatic ON confirmed by imaging. We completed time-to-ON and logistic regression of ON genome-wide association studies (GWASs) with covariates for sex, age of SLE diagnosis, five PCs for ancestry, corticosteroid use and selected SLE manifestations. We conducted separate analyses for cSLE and aSLE and meta-analysed results using inverse-variance weighting. Genome-wide significance was P < 5 × 10-8. RESULTS: The study included 940 participants with SLE, 87% female and 56% with cSLE. ON was present in 7.6% (n = 71). Median age of SLE diagnosis was 16.9 years (interquartile range [IQR]: 13.5, 29.3), with median follow-up of 8.0 years (IQR: 4.2, 15.7). Meta-GWAS of cSLE and aSLE time-to-ON of 4 431 911 SNPs identified a significant Chr.2 SNP, rs34118383 (minor allele frequency = 0.18), intronic to WIPF1 (hazard ratio = 3.2 [95% CI: 2.2, 4.8]; P = 1.0 × 10-8). CONCLUSION: We identified an intronic WIPF1 variant associated with a 3.2 times increased hazard for ON (95% CI: 2.2, 4.8; P = 1.0 × 10-8) during SLE follow-up, independent of corticosteroid exposure. The effect of the SNP on time-to-ON was similar in cSLE and aSLE. This novel discovery represents a potential ON risk locus. Our results warrant replication.
引用
- Webber D, Cao J, Dominguez D, et al. Genetics of osteonecrosis in children and adults with systemic lupus erythematosus. Rheumatology (Oxford). 2023. PMID: 36651668. doi:10.1093/rheumatology/kead016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。